Results 251 to 260 of about 3,949,650 (302)

Dopamine Pharmacological Agents in Resistant-OCD

Current Psychopharmacologye, 2012
Stefano Pallanti, Giacomo Grassi, Iuliia Burian   +2 more
openaire   +1 more source

Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.

Chemical Reviews, 2013
Na Ye, J. Neumeyer, R. Baldessarini, Xuechu Zhen, A. Zhang   +4 more
semanticscholar   +1 more source

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Dopamine‐Melanin Colloidal Nanospheres: An Efficient Near‐Infrared Photothermal Therapeutic Agent for In Vivo Cancer Therapy

Advances in Materials, 2013
Yanlan Liu, K. Ai, Jianhua Liu, Mo Deng, Yangyang He, Lehui Lu   +5 more
semanticscholar   +1 more source

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.

Journal of Medicinal Chemistry, 2009
S. Butini, S. Gemma, G. Campiani, S. Franceschini, F. Trotta, M. Borriello, N. Ceres, S. Ros, Salvatore Sanna Coccone, Matteo Bernetti, Meri De Angelis, M. Brindisi, V. Nacci, I. Fiorini, E. Novellino, A. Cagnotto, T. Mennini, K. Sandager‐Nielsen, J. T. Andreasen, J. Scheel-Kruger, J. Mikkelsen, C. Fattorusso   +21 more
semanticscholar   +1 more source

CLEBOPRIDE: A DOPAMINE RECEPTOR BLOCKING AGENT

InPharma, 1982
openaire   +1 more source

Dopamine Receptor Agents

2007
openaire   +1 more source